Emtricitabin/tenofovirdizoproksil Remedica 200 mg/245 mg filmom obložene tablete
| Name | Emtricitabin/tenofovirdizoproksil Remedica 200 mg/245 mg filmom obložene tablete |
|---|---|
| Former Name | Emtricitabin/tenofovirdizoproksil Alpha-Medical 200 mg/245 mg filmom obložene tablete |
| Marketing Authorisation Number | HR-H-279516622 |
| Active Substance | emtricitabin tenofovirdizoproksilsukcinat |
| Composition | jedna filmom obložena tableta sadrži 200 mg emtricitabina i 245 mg tenofovirdizoproksila (u obliku tenofovirdizoproksilsukcinata) |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Remedica Ltd., Limassol, Cipar |
| Marketing Authorisation Holder | Remedica Ltd., Aharnon Street, Limassol Industrial Estate, Limassol, Cipar |
| Marketing Authorisation Date | 03.03.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/87 |
| Registration Number | 381-12-01/38-22-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J05AR03 |
| Marketing status | trajni prekid opskrbe |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
